Literature DB >> 12684293

The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD.

Joanna Domagała-Kulawik1, Marta Maskey-Warzechowska, Izabela Kraszewska, Ryszarda Chazan.   

Abstract

STUDY
OBJECTIVES: The relationship between smoking and COPD has been well-documented. We investigated the impact of cigarette smoking on airway inflammation in COPD patients.
DESIGN: Changes in cell profiles in induced sputum (IS) samples from smokers with COPD and patients who ceased smoking were compared.
SETTING: Department of pneumonology in a university hospital. PATIENTS: IS samples were collected from 17 smokers and 17 ex-smokers with COPD.
INTERVENTIONS: We examined IS samples for differential cell counts and macrophage phenotypes determined by immunocytochemistry with monoclonal antibodies anti-CD11b, anti-CD14, anti-CD54, and anti-CD71. MEASUREMENTS AND
RESULTS: The median IS volume was greater and the total cell count was higher in smokers than in ex-smokers. The difference, however, was not significant. We did not find any significant differences in the proportions of cells and in the phenotypes of macrophages between the two groups, with the proportion of eosinophils being slightly higher in the group of smokers. We found, however, a significant positive correlation between the decrease in pulmonary function parameters and the number of pack-years smoked, an inverse correlation of pulmonary function test results with the number of lymphocytes in IS, and a correlation between some changes in the expression of macrophage surface markers and smoking history. There was no correlation between the time from smoking cessation and any cellular component found in IS samples.
CONCLUSIONS: The analysis of IS samples in patients with COPD revealed no significant differences in cell count and macrophage phenotypes between active smokers and ex-smokers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684293     DOI: 10.1378/chest.123.4.1054

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model.

Authors:  Christopher J Harvey; Rajesh K Thimmulappa; Sanjay Sethi; Xiaoni Kong; Lonny Yarmus; Robert H Brown; David Feller-Kopman; Robert Wise; Shyam Biswal
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

2.  Examining the efficacy of DVD technology compared to print-based material in COPD self-management education of rural patients.

Authors:  Michael Stellefson; Beth H Chaney; J Don Chaney
Journal:  Calif J Health Promot       Date:  2009-12

Review 3.  Impact of smoking on inflammation: overview of molecular mechanisms.

Authors:  R B Gonçalves; R D Coletta; K G Silvério; L Benevides; M Z Casati; J S da Silva; F H Nociti
Journal:  Inflamm Res       Date:  2011-02-05       Impact factor: 4.575

Review 4.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

5.  Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.

Authors:  J M Löfdahl; J Wahlström; C M Sköld
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

6.  Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers.

Authors:  Izolde Bouloukaki; Maria Tsoumakidou; Constantine I Vardavas; Ioanna Mitrouska; Eleni Koutala; Nikolaos M Siafakas; Sophia E Schiza; Nikos Tzanakis
Journal:  Mediators Inflamm       Date:  2010-02-23       Impact factor: 4.711

Review 7.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

8.  AT-RvD1 Mitigates Secondhand Smoke-Exacerbated Pulmonary Inflammation and Restores Secondhand Smoke-Suppressed Antibacterial Immunity.

Authors:  Tariq A Bhat; Suresh Gopi Kalathil; Paul N Bogner; Paul V Lehmann; Thomas H Thatcher; Patricia J Sime; Yasmin Thanavala
Journal:  J Immunol       Date:  2021-02-08       Impact factor: 5.422

9.  Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.

Authors:  Leda Guzmán; María Soledad Depix; Ana María Salinas; Rosa Roldán; Francisco Aguayo; Alejandra Silva; Raul Vinet
Journal:  Diagn Pathol       Date:  2012-07-20       Impact factor: 2.644

10.  Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.

Authors:  Agne Babusyte; Kristina Stravinskaite; Jolanta Jeroch; Jan Lötvall; Raimundas Sakalauskas; Brigita Sitkauskiene
Journal:  Respir Res       Date:  2007-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.